Two suspected overdose cases in infants


TGA issues warning over topical prilocaine/lidocaine cream after receiving notifications for serious adverse events The TGA is reminding health professionals and parents to “use no more than the recommended amount” of EMLA (topical prilocaine/lidocaine cream) following its investigation of serious adverse events in infants. In the two reported cases, the cream was used as topical

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Shortage remains despite record numbers
Next Telehealth guidance expanded